Draegerwerk AG & Co KGaA (DRW3) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Draegerwerk AG & Co KGaA (ETR:DRW3) have been assigned a consensus recommendation of “Hold” from the seven analysts that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is €44.57 ($51.83).

DRW3 has been the subject of several research reports. Warburg Research set a €49.00 ($56.98) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research note on Thursday, April 25th. Nord/LB set a €45.00 ($52.33) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research note on Friday, April 26th. Independent Research set a €43.00 ($50.00) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “sell” rating in a research note on Monday, April 29th. Deutsche Bank set a €46.00 ($53.49) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research note on Tuesday, April 30th. Finally, Hauck & Aufhaeuser set a €42.00 ($48.84) price objective on shares of Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research note on Monday, March 11th.

Shares of ETR DRW3 traded down €0.20 ($0.23) during trading hours on Wednesday, hitting €52.50 ($61.05). 13,185 shares of the stock were exchanged, compared to its average volume of 33,804. The company has a current ratio of 1.98, a quick ratio of 1.17 and a debt-to-equity ratio of 20.16. The firm has a market capitalization of $932.40 million and a price-to-earnings ratio of 21.21. Draegerwerk AG & Co KGaA has a 1-year low of €42.08 ($48.93) and a 1-year high of €73.00 ($84.88).



Draegerwerk AG & Co KGaA Company Profile

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Further Reading: How Important is Technical Analysis of Stocks

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.